D-1273-2019 Class II Terminated
FDA drug recall D-1273-2019 was initiated by Zydus Pharmaceuticals USA Inc on Apr 25, 2019 and is designated Class II. Reason for recall: Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg The recall status is terminated (terminated Jun 29, 2021). Affected quantity: 3900.
Recall details
- Product Type
- Drugs
- Report Date
- May 15, 2019
- Initiation Date
- Apr 25, 2019
- Termination Date
- Jun 29, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3900
Product description
Carvedilol Tablets, USP, 6.25 mg, 500 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-093-05
Reason for recall
Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg
Distribution pattern
Nationwide
Code information
Z804517, exp Nov 30, 2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1273-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026